← Eichor
Condition: Cardiogenic Shock Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Cardiogenic Shock

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

OPTIMIZE 5.5 - Optimizing Impella 5.5 Outcomes Through Advanced Data Science
Phase N/A · 1 location(s) · Medical University of Vienna · NCT07619144Magenta Elevate™ Clinical Feasibility Study in Cardiogenic Shock
NA · 8 location(s) · Magenta Medical Ltd. · NCT07293923Rapid Microaxial Flow Pump Support and Escalation in Patients With Myocardial Infarction Associated Cardiogenic Shock an
Phase N/A · 1 location(s) · University Hospital of Cologne · NCT07655479Revascularization Strategy of Multivessel Disease for Patients with Acute Myocardial Infarction Complicated by Cardiogen
Phase 4 · 1 location(s) · Samsung Medical Center · NCT05527717Cardiac Power Output in Cardiogenic Shock Patients
EARLY_Phase 1 · 1 location(s) · University of Chicago · NCT05700617Study of Patients Admitted to a Cardiac Intensive Care Unit With Acute CardioVascular Disease
Phase N/A · 1 location(s) · University Hospital, Ioannina · NCT06081205Ivabradine in the Acute Management of Cardiogenic Shock
Phase 3 · 1 location(s) · National Institute of Cardiovascular Diseases, Pakistan · NCT07714746Early Beta Blocker Administration in STEMI Patients With SCAI B Status
NA · 1 location(s) · Tel-Aviv Sourasky Medical Center · NCT06967194Prolonged Nasogastric Administration of Ketones in Decompensated Heart Failure
Phase 4 · 1 location(s) · Institute for Clinical and Experimental Medicine · NCT07527156Multi-center Collaborative to Enhance Quality and Outcomes in the Management of Cardiogenic Shock
Phase N/A · 3 location(s) · STAVROS G DRAKOS · NCT05185492Prognostic Value of the Rockwood Clinical Frailty Score in Cardiogenic Shock
Phase N/A · 1 location(s) · University Hospital, Strasbourg, France · NCT06692855Genomic Determinants of Outcome in Cardiogenic Shock
Phase N/A · 1 location(s) · Barts & The London NHS Trust · NCT05728359Lower Silesia Cardiogenic Shock Initiative
Phase N/A · 1 location(s) · Wroclaw Medical University · NCT05465200The Role of Swan-Ganz Catheter in Hemodynamic Resuscitation for Patients With Cardiogenic Shock
NA · 1 location(s) · Bach Mai Hospital · NCT07062744IMPELLA, Complications and Tolerance
Phase N/A · 1 location(s) · University Hospital, Montpellier · NCT06644963Incidence and Morbidity of Cardiac Rhythm Disorders in Patients Assisted by ECMO-VA for Refractory Cardiogenic Shock
Phase N/A · 20 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05788120Clinical Characteristics and Outcomes Among STEMI Patients With Cardiogenic Shock at Abu Dhabi City
Phase N/A · 2 location(s) · Abu Dhabi Health Services Company · NCT06535503ECMO LEft Ventricle UNloading Strategy
Phase N/A · 1 location(s) · Maastricht University Medical Center · NCT06766006Impella Reverse Remodeling in End-Stage Heart Failure
Phase N/A · 1 location(s) · Columbia University · NCT06800716Cangrelor on Top of anticoagUlation in Patients With myocaRdial Infarction-related Cardiogenic Shock/Cardiac Arrest rece
Phase 2 · 1 location(s) · IRCCS San Raffaele · NCT06792643Digital Out-of-hospital Management on Clinical Outcomes in Patients With Early Cardiogenic Shock
NA · 1 location(s) · Renmin Hospital of Wuhan University · NCT07085221BEAT-SHOCK Registry
Phase N/A · 1 location(s) · University Hospital, Basel, Switzerland · NCT07643610Cardiogenic Shock Integrated PHenotyping for Event Reduction
Phase N/A · 1 location(s) · Niguarda Hospital · NCT04323371China Extracorporeal Life Support Registry
Phase N/A · 1 location(s) · Beijing Anzhen Hospital · NCT04158479Pulmonary Artery Catheter in Cardiogenic Shock Trial
NA · 1 location(s) · Tufts Medical Center · NCT05485376REMAP ECMO - Beta Receptor Modulation Trial
Phase 2 · 1 location(s) · Erasmus Medical Center · NCT06522594Left Ventricular Physiological Effects of Veno-Arterial Extracorporeal Membrane Oxygenation Support During Cardiogenic S
Phase N/A · 1 location(s) · University of Minnesota · NCT05426083Abiomed Impella RT-DAQ - Observational Study
Phase N/A · 4 location(s) · Abiomed Inc. · NCT06308055Effect of Early Use of Levosimendan Versus Placebo on Top of a Conventional Strategy of Inotrope Use on a Combined Morbi
Phase 3 · 28 location(s) · Pr Bruno LEVY · NCT04020263Inova Cardiogenic Shock Registry (INOVA SHOCK)
Phase N/A · 1 location(s) · Inova Health Care Services · NCT03378739
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.